KEYTRUDA & Role in Stage 4 Melanoma | Immunotherapy has Long-Term Benefits After Treatment

KEYTRUDA & Role in Stage 4 Melanoma | Immunotherapy has Long-Term Benefits After Treatment

User Photo
moasc

2 years
122 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
John P. Fruehauf, MD, UC Irvine Health, explains KEYTRUDA & Role in Stage 4 Melanoma | Immunotherapy has Long-Term Benefits After Treatment at MOASC 2018
Up Next Autoplay
>